These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37261720)

  • 1. Improvement of deep learning prediction model in patient-specific QA for VMAT with MLC leaf position map and patient's dose distribution.
    Tozuka R; Kadoya N; Tomori S; Kimura Y; Kajikawa T; Sugai Y; Xiao Y; Jingu K
    J Appl Clin Med Phys; 2023 Oct; 24(10):e14055. PubMed ID: 37261720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive gamma passing rate of 3D detector array-based volumetric modulated arc therapy quality assurance for prostate cancer via deep learning.
    Matsuura T; Kawahara D; Saito A; Miura H; Yamada K; Ozawa S; Nagata Y
    Phys Eng Sci Med; 2022 Dec; 45(4):1073-1081. PubMed ID: 36202950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Error detection model developed using a multi-task convolutional neural network in patient-specific quality assurance for volumetric-modulated arc therapy.
    Kimura Y; Kadoya N; Oku Y; Kajikawa T; Tomori S; Jingu K
    Med Phys; 2021 Sep; 48(9):4769-4783. PubMed ID: 34101848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
    Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
    Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthesized gamma distribution-based patient-specific VMAT QA using a generative adversarial network.
    Matsuura T; Kawahara D; Saito A; Yamada K; Ozawa S; Nagata Y
    Med Phys; 2023 Apr; 50(4):2488-2498. PubMed ID: 36609669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
    Coleman L; Skourou C
    Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online adaptation and verification of VMAT.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy.
    Kimura Y; Kadoya N; Oku Y; Jingu K
    J Radiat Res; 2023 Jul; 64(4):728-737. PubMed ID: 37177789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning models to predict the delivered positions of Elekta multileaf collimator leaves for volumetric modulated arc therapy.
    Sivabhaskar S; Li R; Roy A; Kirby N; Fakhreddine M; Papanikolaou N
    J Appl Clin Med Phys; 2022 Aug; 23(8):e13667. PubMed ID: 35670318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy.
    Moon YM; Bae SI; Han MJ; Jeon W; Yu T; Choi CW; Kim JY
    Technol Cancer Res Treat; 2021; 20():15330338211059937. PubMed ID: 34821195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-generated decision boundaries for prediction and exploration of patient-specific quality assurance failures in stereotactic radiosurgery plans.
    Braun J; Quirk S; Tchistiakova E
    Med Phys; 2022 Mar; 49(3):1955-1963. PubMed ID: 35064564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance for online adapted treatment plans: benchmarking and delivery monitoring simulation.
    Li T; Wu Q; Yang Y; Rodrigues A; Yin FF; Jackie Wu Q
    Med Phys; 2015 Jan; 42(1):381-90. PubMed ID: 25563278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer.
    Li MH; Huang SF; Chang CC; Lin JC; Tsai JT
    J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of patient-specific quality assurance for volumetric modulated arc therapy using radiomics-based machine learning with dose distribution.
    Ishizaka N; Kinoshita T; Sakai M; Tanabe S; Nakano H; Tanabe S; Nakamura S; Mayumi K; Akamatsu S; Nishikata T; Takizawa T; Yamada T; Sakai H; Kaidu M; Sasamoto R; Ishikawa H; Utsunomiya S
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14215. PubMed ID: 37987544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing knowledge from prior plans in the evaluation of quality assurance.
    Stanhope C; Wu QJ; Yuan L; Liu J; Hood R; Yin FF; Adamson J
    Phys Med Biol; 2015 Jun; 60(12):4873-91. PubMed ID: 26056801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
    Park SY; Kim IH; Ye SJ; Carlson J; Park JM
    Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a plan complexity mitigation algorithm based on gamma passing rate predictions for volumetric-modulated arc therapy.
    Ono T; Nakamura M; Ono Y; Nakamura K; Mizowaki T
    Med Phys; 2022 Mar; 49(3):1793-1802. PubMed ID: 35064567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.
    Huang Y; Pi Y; Ma K; Miao X; Fu S; Zhu Z; Cheng Y; Zhang Z; Chen H; Wang H; Gu H; Shao Y; Duan Y; Feng A; Zhuo W; Xu Z
    Technol Cancer Res Treat; 2022; 21():15330338221104881. PubMed ID: 35726209
    [No Abstract]   [Full Text] [Related]  

  • 19. Using machine learning to predict gamma passing rate in volumetric-modulated arc therapy treatment plans.
    Salari E; Shuai Xu K; Sperling NN; Parsai EI
    J Appl Clin Med Phys; 2023 Feb; 24(2):e13824. PubMed ID: 36495010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting gamma evaluation results of patient-specific head and neck volumetric-modulated arc therapy quality assurance based on multileaf collimator patterns and fluence map features: A feasibility study.
    Thongsawad S; Srisatit S; Fuangrod T
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13622. PubMed ID: 35584035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.